MG53是心脏缺血预调的一个主要决定因素
Chun-Mei Cao1, Yan Zhang, Noah Weisleder
1Institute of Molecular Medicine, Peking University, Beijing, China.
Circulation
|June 3, 2010
概括
肌肉蛋白MG53是心脏缺血预制 (IPC) 保护的关键. 缺少MG53会恶化心脏损伤,而它的存在会保护心脏细胞,为缺血性心脏病提供了一个新的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 细胞信号传输 细胞信号传输
背景情况:
- 缺血性心脏病是西方国家死亡的主要原因.
- 缺血预制 (IPC) 暂时保护心脏免受严重的缺血/反 (I/R) 损伤.
- IPC激活复杂的信号通路,但其核心机制尚不清楚.
研究的目的:
- 确定心脏缺血预先调节 (IPC) 的新型分子组成部分.
- 研究肌肉特异性TRIM家族蛋白MG53在心脏IPC中的作用.
- 探索MG53作为缺血性心脏病的潜在治疗点.
主要方法:
- 使用过的小鼠心脏和新生小鼠心肌细胞,经过缺血/反或缺氧/氧化应激.
- 在各种压力条件和IPC下评估MG53表达水平.
- 研究了MG53过度表达和敲击对心肌细胞存活的影响.
- 检查了MG53与卡韦林-3和酸氨基醇3激酶的相互作用.
主要成果:
- MG53的表达受到缺血/再输和缺氧/氧化应激的下调.
- IPC可以防止由缺血/再输引起的MG53表达的下降.
- 缺少MG53会加剧心肌肌肉对I/R损伤的脆弱性,并取消IPC的好处.
- 过度表达MG53可以保护心肌细胞,而降低MG53会增加细胞死亡.
- MG53通过反注射伤害救援激酶通路中的caveolin-3和PI3K相互作用来调解心脏保护.
结论:
- MG53被认为是心脏IPC机械的关键组成部分.
- MG53在保护心脏免受 ischemia/reperfusion损伤方面发挥着至关重要的作用.
- MG53代表了治疗缺血性心脏病的一个有前途的新型治疗标.
相关概念视频
Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


